227 related articles for article (PubMed ID: 20676325)
21. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
[TBL] [Abstract][Full Text] [Related]
22. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
Lee HS; Kim BH; Cho NY; Yoo EJ; Choi M; Shin SH; Jang JJ; Suh KS; Kim YS; Kang GH
Clin Cancer Res; 2009 Feb; 15(3):812-20. PubMed ID: 19188151
[TBL] [Abstract][Full Text] [Related]
23. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
24. [The Evaluation Value of Methylation Status of CpG Island of SFRP1 and LINE1 Gene Promoter Area in the Prognosis of Hepatocellular Carcinoma.].
Huang Y; Wei L; Sun AM; Zhao RC; Zhang J; Yang HT; Li B; Sun CJ; Ding XQ; Gao B; Zhong YQ; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):883-888. PubMed ID: 28598118
[TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
Yuan BZ; Durkin ME; Popescu NC
Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648
[TBL] [Abstract][Full Text] [Related]
26.
Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
[TBL] [Abstract][Full Text] [Related]
27. Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.
Kron K; Pethe V; Briollais L; Sadikovic B; Ozcelik H; Sunderji A; Venkateswaran V; Pinthus J; Fleshner N; van der Kwast T; Bapat B
PLoS One; 2009; 4(3):e4830. PubMed ID: 19283074
[TBL] [Abstract][Full Text] [Related]
28. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
[TBL] [Abstract][Full Text] [Related]
29. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis.
Qin Y; Liu JY; Li B; Sun ZL; Sun ZF
World J Gastroenterol; 2004 May; 10(9):1276-80. PubMed ID: 15112341
[TBL] [Abstract][Full Text] [Related]
30. Methylation profile of the promoter CpG islands of 14 "drug-resistance" genes in hepatocellular carcinoma.
Ding S; Gong BD; Yu J; Gu J; Zhang HY; Shang ZB; Fei Q; Wang P; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3433-40. PubMed ID: 15526362
[TBL] [Abstract][Full Text] [Related]
31. Frequent methylation of HOXA9 gene in tumor tissues and plasma samples from human hepatocellular carcinomas.
Kuo CC; Lin CY; Shih YL; Hsieh CB; Lin PY; Guan SB; Hsieh MS; Lai HC; Chen CJ; Lin YW
Clin Chem Lab Med; 2014 Aug; 52(8):1235-45. PubMed ID: 24681432
[TBL] [Abstract][Full Text] [Related]
32. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
33. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
34. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721.
Fan H; Zhao Z; Quan Y; Xu J; Zhang J; Xie W
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):952-61. PubMed ID: 18049164
[TBL] [Abstract][Full Text] [Related]
35. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.
Tchou JC; Lin X; Freije D; Isaacs WB; Brooks JD; Rashid A; De Marzo AM; Kanai Y; Hirohashi S; Nelson WG
Int J Oncol; 2000 Apr; 16(4):663-76. PubMed ID: 10717233
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic Activation of Cytochrome P450 1A2 Sensitizes Hepatocellular Carcinoma Cells to Sorafenib.
Zhang Y; Feng J; Mi Y; Fan W; Qin R; Mei Y; Jin G; Mao J; Zhang H
Drug Metab Dispos; 2024 May; 52(6):555-564. PubMed ID: 38565301
[TBL] [Abstract][Full Text] [Related]
37. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
[TBL] [Abstract][Full Text] [Related]
39. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.
Anwar SL; Albat C; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
Int J Cancer; 2013 Aug; 133(3):660-70. PubMed ID: 23364900
[TBL] [Abstract][Full Text] [Related]
40. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
